Treasury Analyst at Legend Biotech

Dublin, County Dublin, Ireland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, BiotechnologyIndustries

Requirements

Bachelor’s Degree required; a major in Accounting or Finance preferred
Professional Certifications: ACT/IACT; CPA/CMA/ACA/ACCA/CIMA (preferred); MBA or advanced degrees (preferred)
A minimum of 3 years of progressive Treasury experience
Prior life sciences industry experience is preferred
Knowledge of SOX financial controls on Accounting and Reporting processes is preferred
Ability to partner and collaborate with all levels of the organization
Ability to prioritise, manage time effectively and escalate issues appropriately
Excellent written and verbal communication skills
Complex modeling and forecasting capabilities with focus on tracking key assumptions
High proficiency with Microsoft Office applications (Excel & PowerPoint) required; Excellent data management and reporting skills required
High proficiency with business reporting and analysis tools (Onestream preferred)
Knowledge of common business and financial drivers and deep-dive analysis
Experience in continuous improvement initiatives, root cause analysis and project management
Experience in ERP systems (SAP, etc) strongly preferred
English is required
Onsite in Dublin, Ireland
Full-time

Responsibilities

Preparation of cash forecasts, Intercompany funding & FX position projections
Reviewing and supporting liquidity optimization and FX management
Preparing management reporting; actual performance, cash management targets, quarterly forecasting, monthly CFO reporting and long range planning
Working closely with Treasury leadership to prepare executive level presentations providing insightful analysis for key stakeholders
Support opening/closing of bank accounts and bank account mandates
Administer online banking systems
Participate in the Vendor onboarding compliance process
Administering and supporting the corporate card and travel accounts
Participate in internal and external audit reviews, information requests and process walkthroughs as needed
Developing and implementing methods and strategies to continually improve processes and enhance controls
Support month-end close activities as needed
Adhoc responsibilities and projects as required

Skills

Cash Forecasting

FX Management

Liquidity Optimization

Treasury Reporting

Bank Account Management

Online Banking

Vendor Onboarding

SOX Controls

Audit Support

Process Improvement

Month-End Close

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free